1027. Deputy Ken O'Flynn asked the Minister for Health if she will commission a comprehensive national report on the prevalence and projected trends of obesity in Ireland, with particular reference to the growing strain it places on the healthcare system and its wider economic impact; if she will undertake a review of international best practices, including the recently proposed NHS model in the United Kingdom, which seeks to allow structured pharmacist-led prescribing of clinically approved weight-loss medications-such as semaglutide (Wegovy) and tirzepatide (Mounjaro)-outside of traditional hospital-based specialist clinics; if she will consider the feasibility of introducing a similar model, enabling responsible access to such medications through community pharmacies or regulated digital platforms under clinical oversight; if she will address the serious public health concern that individuals are increasingly sourcing unregulated or potentially counterfeit versions of these drugs online without medical consultation, leading to significant risks including overdose, misuse, and exposure to unsafe or fraudulent substances; and if she will make a statement on the matter. [23434/25]

Summary

1027. Deputy Ken O'Flynn asked the Minister for Health if she will commission a comprehensive national report on the prevalence and projected trends of obesity in Ireland, with particular reference to the growing strain it places on the healthcare system and its wider economic impact; if she will undertake a review of international best practices, including the recently proposed NHS model in the United Kingdom, which seeks to allow structured pharmacist-led prescribing of clinically approved weight-loss medications-such as semaglutide (Wegovy) and tirzepatide (Mounjaro)-outside of traditional hospital-based specialist clinics; if she will consider the feasibility of introducing a similar model, enabling responsible access to such medications through community pharmacies or regulated digital platforms under clinical oversight; if she will address the serious public health concern that individuals are increasingly sourcing unregulated or potentially counterfeit versions of these drugs online without medical consultation, leading to significant risks including overdose, misuse, and exposure to unsafe or fraudulent substances; and if she will make a statement on the matter. [23434/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Obesity Levels

  xml · EN · 13 May 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.